Gingival enlargement in thalassemia patient – A Conjectural Association
Abstract
Thalassemia is a single gene inherited blood disease. Beta thalassemia major is life threating. It causes abnormality in various organs and oral-facial region. Thalassemia patients are immune-deficient because of iron-overload. Immune system abnormality includes neutrophilic dysfunction and impairment of phagocytosis by the monocyte-macrophage system. Iron accumulation also affects periodontal tissues, which seems to increase the level of cytokines and thus have an enhancing effect on gingival inflammation. This article highlights a peculiar case of gingival enlargement in anterior maxilla and mandible. The patient was known case of a beta-thalassemia major. Blood investigation revealed a lower level of hemoglobin. The patient underwent non-surgical periodontal therapy. Proper periodontal care improves the quality of life in these patients. This case report reinforces the significance of proper history taking with all minor details and the role of patient education in phase I therapy
References
2. Renzo G, Raffaella O. Beta Thalassemia Orphanet J Rare Dis Res Treat 2010; 5:11.
3. Brittenham, GM, Patricia GM, Arthur NW, Christine ME, Young NS. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major NEJM Catal 1994; 331:567–573.
4. Kumar N and Hattab FN. Dental care. In: Cappellini MD, Cohen A, Porter J, editors. Textbook of Guidelines for the management of transfusion dependent thalassaemia (TDT), 3rd ed. Nicosia (CY): Thalassaemia International Federation; 2014. p. 178-185.
5. Caliskan U, Tonguc MO, Ciiris M, Balta N, Kirzioglu FY, Caglayan G et al. The investigation of gingival iron accumulation in thalassemia major patients J Pediatr Hematol Oncol 2011; 33:98-102.
6. Sakshi M, Saksham M. Dental consideration in thalassemic patients Journal of Dental and Medical Sciences 2014; 13:57-62.
7. Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies Baillieres Clin Haematol. 1998; 11:1-51.
8. Aydinok Y. Infections. In: Cappellini MD, Cohen A, Porter J, editors. Textbook of Guidelines for the management of transfusion dependent thalassaemia (TDT), 3rd ed. Nicosia (CY): Thalassaemia International Federation; 2014. p. 134-145.
9. Rahav G, Volach V, Shapiro M, Rund D, Rachmilewitz AE, Goldfarb A. Severe infections in thalassemic patients: prevalence and predisposing factors Br J Haematol 2006;133:667-674.
10. Farmakis D, Giakoumis A, Polymeropoulos E, Aessopos A. Pathogenetic aspects of immune deficiency associated with β thalassemia Med Sci Monit, 2003;9:19-22
11. De Luca C, Filosa A, Grandinetti M, Maggio F, Lamba M, Passi S. Blood antioxidant status and urinary levels of catecholamine metabolities in beta- thalassemia Free Radic Res 1999;30:453-462.
12. Moores J. Vitamin C: a wound healing perspective Br J Community Nurs 2013; S6:S8-11.
13. Trinchero A, Marchetti M, Glaccherini C, Tartari C, Russo L, Falanga A. Platelet haemostatic properties in beta thalassemia : The effect of blood transfusion Blood Transfus 2017;5:413-421.
14. Akcali A, Kahraman Ceneli S, Gumus P, Buduneli N, Lappin DF, Ozcaka O. The association between thalassemia major and periodontal health J Periodontol 2015;86:1047-1057
